EULAR 2020: Lilly shares new data for Olumiant in rheumatoid arthritis and systemic lupus erythematosus.
Eli Lilly and Company will present new data for Olumiant (baricitinib) at the virtual European Congress of Rheumatology (EULAR 2020) taking place June 3-6, 2020. Highlights from Olumiant… read more.